Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CM326 in Chronic Rhinosinusitis With Nasal Polyposis
NCT06372678Phase 2Not yet recruiting
- Sponsor
- Keymed Biosciences
- Start
- Jun 2024
- Primary completion
- Jun 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of CM326 in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Keymed Biosciences. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
CM326
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT06372678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06372678.